This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA is a proud sponsor of the congress.
Cecile Matthews and Bhavesh Patel present their session titled “Project LEOPARD (Long-term Evolution & Outlook for Patient Access in Rare Disease): Initial findings on what the future holds.”
Michele Pistollato presents his session titled “Policy perspectives: Can the care for patients with rare diseases be improved?”
For more information on this event, click here.
Direct oral anticoagulants (DOACs) are widely used pharmaceutical products which represent a significant cost to the healthcare system. In 2021, National...
CRA’s Life Sciences Practice team recently analyzed past predictions of industry trends and compared them to what has occurred in the past decade, identified...
